Analgesic Solutions Leadership Structure Update
WAYLAND, Mass., /PRNewswire/ — Analgesic Solutions LLC, a company that focuses on increasing assay sensitivity in the conduct of clinical trials through consulting, innovative tools, data science, technology and training, announced today changes within its leadership structure. Effective immediately, is promoted to Chief Executive Officer from Chief Operating Officer, , MD, MS will move from Chief Executive Officer to Founder & Chief Scientific Officer, promoted to Chief Operating Officer from Vice President, Operations, and , Ph.D. will assume the title Chief Technology & Data Officer.
Arturo Morales, Ph.D. joined the company in as Chief Technology Officer. Upon completing his doctoral work with Dr. at (), Dr. Morales started his industry career with Genome Therapeutics as a Senior Computational Biologist. He subsequently led a variety of biology, IT and data science teams at various companies, including the Novartis Institutes for Biomedical Research, where he was Global Lead for Biology Platform Informatics.
Analgesic Solutions, LLC, founded in 2006, is a privately held company focused on increasing assay sensitivity in the conduct of pain clinical trials through consulting, innovative tools and technology, and training. Our team, with Nathaniel Katz M.D., M.S., serving as our foremost expert, helps clients develop and commercialize better treatments for pain. With hundreds of projects completed and ongoing collaborations with regulatory authorities, Analgesic Solutions is the expert at identifying and mitigating the random and systematic errors that lead to negative clinical trials.